Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19

More than 3.5 million people have died globally from COVID-19, yet an effective therapy is not available. It is, therefore, important to understand the signaling pathways that mediate disease progression in order to identify new molecular targets for therapeutic development. Here, we report that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendoza, Rachelle, Saha, Nayanendu, Momeni, Amir, Gabutan, Elmer, Alawad, Mouyed, Dehghani, Amir, Diks, John, Lin, Bo, Wang, Donghai, Alshal, Mohamed, Fyke, William, Wang, Bingcheng, Himanen, Juha P., Premsrirut, Prem, Nikolov, Dimitar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165044/
https://www.ncbi.nlm.nih.gov/pubmed/34095559
http://dx.doi.org/10.1016/j.heliyon.2021.e07200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165044/
https://www.ncbi.nlm.nih.gov/pubmed/34095559
http://dx.doi.org/10.1016/j.heliyon.2021.e07200

Ejemplares similares